The determination and measurement of functional disability in rheumatoid arthritis (Q34731281)

4 August 2017

6 references

13 March 2019

17 June 2019

29 June 2019

30 June 2019

19 September 2019

20 October 2020

The determination and measurement of functional disability in rheumatoid arthritis (English)

1 reference

biomedical investigative technique

4 August 2017

0 references

6 references

13 March 2019

17 June 2019

29 June 2019

30 June 2019

19 September 2019

20 October 2020

1 reference

19 September 2019

1 reference

20 October 2020

1

Frederick Wolfe

1 reference

4 August 2017

publication date

8 April 2002

7 references

Arthritis Research and Therapy

4 August 2017

13 March 2019

17 June 2019

29 June 2019

30 June 2019

19 September 2019

20 October 2020

1 reference

4 August 2017

volume

4 Suppl 2

1 reference

4 August 2017

page(s)

S11-5

1 reference

https://scigraph.springernature.com/pub.10.1186/ar547

4 August 2017

exact match

0 references

cites work

Markers for work disability in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Monitoring health outcomes among patients with arthritis using the SF-36 Health Survey: overview

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

The earnings, income, and assets of persons aged 51-61 with and without musculoskeletal conditions.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

The mortality of rheumatoid arthritis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

The MOS 36-ltem Short-Form Health Survey (SF-36)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Usefulness of the HAQ in the clinic

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Mortality in rheumatoid arthritis: have we made an impact in 4 decades?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Measuring health status in arthritis. The arthritis impact measurement scales.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3238215

Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study

26 October 2018

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Predictors of extra-articular manifestations in rheumatoid arthritis

1 reference

12 December 2020

A reappraisal of HAQ disability in rheumatoid arthritis

1 reference

12 December 2020

Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity

1 reference

12 December 2020

The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

[Work disability work in the first year of chronic polyarthritis. A comparison with members of the legal health health insurance]

1 reference

12 December 2020

The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR547

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference